Growth Metrics

Omeros (OMER) Amortizatization of Intangibles (2023 - 2024)

Omeros recorded quarterly Amortizatization of Intangibles of $76000.0 in Q4 2024, down 91.39% quarter-over-quarter from $883000.0 in Q3 2024, and down 94.7% year-over-year from $1.4 million in Q1 2024.

Omeros' Amortizatization of Intangibles history runs 2 years deep, the most recent figure standing at $76000.0 for Q4 2024.

  • In Q4 2024, Amortizatization of Intangibles fell 94.7% year-over-year to $76000.0; the TTM figure through Sep 2025 stood at $76000.0 (down 98.67% YoY), while the FY2024 annual figure was $4.4 million, down 49.84% from the prior year.
  • Amortizatization of Intangibles came in at $76000.0 for Q4 2024 at Omeros, down from $883000.0 in the prior quarter.
  • In the past five years, Amortizatization of Intangibles ranged from a high of $2.8 million in Q2 2023 to a low of $76000.0 in Q4 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Amortizatization of Intangibles (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 13,267.00
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn -
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn -
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn -
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn -
10 Omeros 772.03 Mn 636.71 Mn 9.31 Mn -

Historic Data

Download Data 🔒
DateValue
Dec 31, 2024 76,000.00
Dec 31, 2024 76,000.00
Sep 30, 2024 883,000.00
Sep 30, 2024 883,000.00
Jun 30, 2024 1.52 Mn
Jun 30, 2024 1.52 Mn
Mar 31, 2024 1.89 Mn
Mar 31, 2024 1.89 Mn
Dec 31, 2023 1.43 Mn
Dec 31, 2023 1.43 Mn
Sep 30, 2023 2.19 Mn
Sep 30, 2023 2.19 Mn
Jun 30, 2023 2.77 Mn
Jun 30, 2023 2.77 Mn
Mar 31, 2023 2.32 Mn
Mar 31, 2023 2.32 Mn